Skip to main content

previous disabled Page of 3
and
  1. No Access

    Article

    How to manage coagulopathies in critically ill patients

    Coagulopathy is a severe and frequent complication in critically ill patients, for which the pathogenesis and presentation may be variable depending on the underlying disease. Based on the dominant clinical ph...

    Julie Helms, Toshiaki Iba, Jean Marie Connors, Satoshi Gando in Intensive Care Medicine (2023)

  2. No Access

    Article

    Inflammation, coagulation, and cellular injury in heat-induced shock

    The number of heatstroke victims hit record numbers in 2022 as global warming continues. In heat-induced injuries, circulatory shock is the most severe and deadly complication. This review aims to examine the ...

    Toshiaki Iba, Julie Helms, Marcel Levi, Jerrold H. Levy in Inflammation Research (2023)

  3. Article

    Open Access

    Nevertheless, the importance of coagulation abnormalities should be emphasized in international sepsis guidelines

    It is generally accepted that a coagulation/fibrinolysis disorder is involved in the pathogenesis of sepsis, and the association of disseminated intravascular coagulation (DIC) and poor outcomes have been repo...

    Toshiaki Iba, Osamu Nishida, Jerrold H. Levy, Marcel Levi in Journal of Intensive Care (2022)

  4. Article

    Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19

    Coronavirus disease 2019 (COVID-19) is a clinical syndrome caused by infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Patients with severe disease show hyperactivation of the immune...

    Aldo Bonaventura, Alessandra Vecchié, Lorenzo Dagna in Nature Reviews Immunology (2021)

  5. Article

    Open Access

    COVID-19 coagulopathy: is it disseminated intravascular coagulation?

    One of the significant complications of severe COVID-19 infections is a coagulopathy that seems to be related to the occurrence of venous and arterial thromboembolic disease. The coagulation changes mimic but ...

    Marcel Levi, Toshiaki Iba in Internal and Emergency Medicine (2021)

  6. Article

    Author Correction: Scalable and robust SARS-CoV-2 testing in an academic center

    An amendment to this paper has been published and can be accessed via a link at the top of the paper.

    Jim Aitken, Karen Ambrose, Sam Barrell, Rupert Beale in Nature Biotechnology (2020)

  7. Article

    Scalable and robust SARS-CoV-2 testing in an academic center

    Jim Aitken, Karen Ambrose, Sam Barrell, Rupert Beale in Nature Biotechnology (2020)

  8. Article

    Open Access

    The unique characteristics of COVID-19 coagulopathy

    Thrombotic complications and coagulopathy frequently occur in COVID-19. However, the characteristics of COVID-19-associated coagulopathy (CAC) are distinct from those seen with bacterial sepsis-induced coagulo...

    Toshiaki Iba, Jerrold H. Levy, Jean Marie Connors, Theodore E. Warkentin in Critical Care (2020)

  9. Article

    Open Access

    Strengths and weaknesses of the acute care systems in the United Kingdom and the Netherlands: what can we learn from each other?

    The demand on Emergency Departments and acute medical services is increasing internationally, creating pressure on health systems and negatively influencing the quality of delivered care. Visible consequences ...

    Marjolein N. T. Kremers, Prabath W. B. Nanayakkara, Marcel Levi in BMC Emergency Medicine (2019)

  10. No Access

    Chapter

    Acquired Bleeding Disorders

    There are several acquired defects in the coagulation system that may lead to bleeding. Most of these conditions can be detected by routinely available coagulation tests, such as the platelet count, prothrombi...

    Marcel Levi in Concise Guide to Hematology (2019)

  11. Article

    What do sepsis-induced coagulation test result abnormalities mean to intensivists?

    Marcel Levi, Marcus J. Schultz in Intensive Care Medicine (2017)

  12. Article

    Open Access

    Management of bleeding in patients treated with direct oral anticoagulants

    Recently, a new generation of direct-acting oral anticoagulants (DOACs) with a greater specificity towards activated coagulation factors was introduced based on encouraging results for efficacy and safety in c...

    Marcel Levi in Critical Care (2016)

  13. No Access

    Article

    Disseminated intravascular coagulation

    Disseminated intravascular coagulation (DIC) is an acquired syndrome characterized by widespread intravascular activation of coagulation that can be caused by infectious insults (such as sepsis) and non-infect...

    Satoshi Gando, Marcel Levi, Cheng-Hock Toh in Nature Reviews Disease Primers (2016)

  14. No Access

    Article

    What’s new in the diagnostic criteria of disseminated intravascular coagulation?

    Satoshi Gando, Ferhat Meziani, Marcel Levi in Intensive Care Medicine (2016)

  15. No Access

    Article

    Hemostatic abnormalities in critically ill patients

    Hemostatic abnormalities frequently occur in critically ill patients and may vary from prolonged global clotting tests or isolated thrombocytopenia, to composite defects, such as consumption coagulopathies. Th...

    Marcel Levi, Suthesh Sivapalaratnam in Internal and Emergency Medicine (2015)

  16. No Access

    Article

    Endothelial injury in sepsis

    Marcel Levi, Tom van der Poll in Intensive Care Medicine (2013)

  17. Article

    Another step in improving the diagnosis of disseminated intravascular coagulation in sepsis

    The diagnosis of disseminated intravascular coagulation (DIC) based on composite scoring systems using routinely available coagulation tests has been greatly facilitated. Such scoring instruments not only adeq...

    Marcel Levi in Critical Care (2013)

  18. No Access

    Article

    Disseminated intravascular coagulation: a review for the internist

    Disseminated intravascular coagulation (DIC) is a syndrome characterized by systemic intravascular activation of coagulation, leading to widespread deposition of fibrin in the circulation. Recent knowledge on ...

    Marcel Levi, Tom van der Poll in Internal and Emergency Medicine (2013)

  19. Article

    Open Access

    Protease-activated receptor-1 impairs host defense in murine pneumococcal pneumonia: a controlled laboratory study

    Streptococcus pneumoniae is the most common causative pathogen in community-acquired pneumonia. Protease-activated receptor-1 (PAR-1) is expressed by multiple cell types present in the lungs and can be activated ...

    Marcel Schouten, Cornelis van't Veer, Joris JTH Roelofs, Marcel Levi in Critical Care (2012)

  20. Article

    Open Access

    Early intravenous unfractionated heparin and outcome in acute lung injury and acute respiratory distress syndrome – a retrospective propensity matched cohort study

    Acute lung injury (ALI) is characterized by a pro-coagulant state. Heparin is an anticoagulant with anti-inflammatory properties. Unfractionated heparin has been found to be protective in experimental models o...

    Jorrit J Hofstra, Alexander P J Vlaar, David J Prins, Gavin Koh in BMC Pulmonary Medicine (2012)

previous disabled Page of 3